BPC-157 Gastric-Derived Peptide

BPC-157 is a synthetic peptide made of 15 amino acids — a fragment of a larger protein found in human gastric juice. Laboratory research has looked at how it interacts with nitric oxide signaling and with pathways tied to new blood-vessel formation. Nearly all of that research is in animals and cells; human data is limited.

No. Compounded BPC-157 is not an FDA-approved drug product. In October 2026 HHS announced an interim policy under which FDA does not intend to take enforcement action against pharmacies compounding single-ingredient BPC-157, TB-500 or MOTS-C under specific conditions — that is not FDA approval. Yours is compounded by a state-licensed U.S. pharmacy for your individual prescription, and only after a licensed provider reviews your health history and decides it is appropriate for you.

BPC-157 (3 mg/mL) is sold as a 1-month plan (5 mL, $219 one-time or $186.15 with auto-refill) or a 2-month plan (2 × 5 mL, $349 one-time or $296.65 with auto-refill) — the 2-month plan saves $89 vs. two 1-month orders. That is what ships and what you pay — your provider sets your dose when they write the prescription, so how long a plan lasts depends on the dose they prescribe. Auto-refill is optional, takes 15% off either plan and cancels anytime; free syringes, alcohol prep pads and cold-chain shipping are included on both.

Both are compounded from the same 15-amino-acid sequence. The injectable is a subcutaneous injection and ships with syringes and alcohol prep pads; the capsule is taken by mouth, with nothing to inject. The two forms have not been compared head to head in people, so there is no evidence that one works better than the other. Whether either fits your health history — and which — is your provider's decision.

We don't promise specific results or a timeline. Compounded BPC-157 is not FDA-approved, most published research on it is in animals and cells, and how people respond varies. Your licensed provider talks through realistic expectations for your health history and sets your dose and schedule when they write your prescription.

Because human research on BPC-157 is limited, its side-effect profile in people is not well characterized. Reported reactions are usually mild — redness, swelling or discomfort at the injection site, nausea, dizziness or headache. As with any injectable, an allergic reaction is possible. Tell your provider about every medication you take, and message your care team if anything doesn't feel right.

Because laboratory research links BPC-157 to blood-vessel-formation signaling, it is generally not prescribed for anyone with active cancer or a history of cancer. It is also not used during pregnancy or breastfeeding, or by anyone allergic to any component of the formulation. Your provider reviews your full health history during intake and won't prescribe it if it isn't appropriate for you.

No — there's no need to come into a clinic. It is given at home with a small, short needle into fatty tissue, and every order ships with sterile syringes and alcohol prep pads, along with step-by-step guidance. Your care team is a message away if you want a walkthrough.